Free Trial

APG Asset Management US Inc. Makes New $591,000 Investment in Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health logo with Medical background
Remove Ads

APG Asset Management US Inc. purchased a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 5,000 shares of the company's stock, valued at approximately $591,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the business. Y Intercept Hong Kong Ltd grew its holdings in shares of Cardinal Health by 15.3% during the third quarter. Y Intercept Hong Kong Ltd now owns 15,203 shares of the company's stock valued at $1,680,000 after buying an additional 2,015 shares during the last quarter. Barclays PLC boosted its position in Cardinal Health by 8.2% in the third quarter. Barclays PLC now owns 707,404 shares of the company's stock valued at $78,183,000 after buying an additional 53,851 shares during the last quarter. M&T Bank Corp increased its holdings in Cardinal Health by 43.2% in the 3rd quarter. M&T Bank Corp now owns 28,326 shares of the company's stock worth $3,131,000 after buying an additional 8,544 shares during the period. Geode Capital Management LLC raised its position in Cardinal Health by 0.7% during the 3rd quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company's stock worth $633,298,000 after buying an additional 42,082 shares during the last quarter. Finally, Coldstream Capital Management Inc. lifted its stake in Cardinal Health by 763.7% during the 3rd quarter. Coldstream Capital Management Inc. now owns 25,763 shares of the company's stock valued at $2,883,000 after acquiring an additional 22,780 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Remove Ads

Cardinal Health Stock Down 0.6 %

NYSE:CAH traded down $0.86 during trading hours on Tuesday, reaching $133.92. 883,505 shares of the company's stock were exchanged, compared to its average volume of 2,178,186. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $139.50. The firm has a market capitalization of $32.35 billion, a price-to-earnings ratio of 24.99, a P/E/G ratio of 1.49 and a beta of 0.61. The company has a 50-day moving average of $129.48 and a 200 day moving average of $122.66.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. Research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 annualized dividend and a dividend yield of 1.51%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Morgan Stanley raised their price objective on shares of Cardinal Health from $136.00 to $142.00 and gave the stock an "overweight" rating in a research note on Friday, January 31st. Mizuho raised their price target on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Argus set a $148.00 price objective on shares of Cardinal Health in a research report on Tuesday, February 4th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and raised their target price for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Finally, Wells Fargo & Company upped their price target on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Four research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $140.86.

Read Our Latest Analysis on Cardinal Health

About Cardinal Health

(Free Report)

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Featured Stories

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Should You Invest $1,000 in Cardinal Health Right Now?

Before you consider Cardinal Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.

While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY Now as Tariff Uncertainty Fades

5 Stocks to BUY Now as Tariff Uncertainty Fades

These 5 Stocks have been beaten down by tariffs, but now that the uncertainty is fading, they're set for a rebound with all the potential downside already priced in.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads